← 홈

Antibody · IBD (크론·대장)

71개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 71개
AntibodystaleUniversity of CalgaryApproved

TNFa Antagonist - Infliximab (TNFa Antagonist - Infliximab)

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Approved#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleRabin Medical CenterPreclinical

adalimumab (Humira, Treatment with Adalimumab)

Crohn's Disease · Crohn's Disease

#CrohnsDisease#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenPreclinical

UST (Ustekinumab, Ustekinumab (UST))

Crohn's Disease · Crohn's Disease

#CrohnsDisease#Antibody#Preclinical#항체#면역항체+2
효능 ORR 3%임상시험 1상태 ACTIVE
AntibodystaleJanssenPreclinical

ustekinumab (Stelara, Ustekinumab - Standard Dosage)

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAbbViePreclinical

ustekinumab (Stelara, adalimumab, infliximab, ustekinumab, golimumab, and vedolizumab)

Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis) · Inflamatory Bowel Disease (Crohn's a

#InflamatoryBowelDiseaseCrohn39sa#Antibody#Preclinical#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleAbbViePhase 3

adalimumab (Humira, azathioprine or adalimumab and infliximab)

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenPreclinical

adalimumab (Humira, infliximab and adalimumab)

Crohn's Disease; Ulcerative Colitis · Crohn's Disease

#CrohnsDisease#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleJanssenPreclinical

infliximab and azathioprine combination at week 0 (infliximab and azathioprine combination at week 0)

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenPreclinical

infliximab and azathioprine combination at week 14 (infliximab and azathioprine combination at week 14)

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenApproved

infliximab therapeutic drug monitoring (infliximab therapeutic drug monitoring)

Crohn Disease; Ulcerative Colitis · Crohn Disease

#CrohnDisease#Antibody#Approved#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleJanssenPreclinical

ustekinumab (Stelara, infliximab, adalimumab, golimumab, vedolizumab, ustekinumab)

Ulcerative Colitis · Ulcerative Colitis

#UlcerativeColitis#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE

4 / 4 페이지

← 이전다음 →